TTrialPathMatch Me to Trials
← Back to trials
RecruitingCataract

Effective Phaco Time and Endothelial Cell Loss When Using Veritas

Eligible age

All ages

Accepts

All genders

Locations

1 state

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

This study is a single center, prospective study of cumulative dissipated energy and endothelial cells loss per phacoemulsification procedure after successful cataract surgery. Subjects will be assessed 3 months postoperatively at a single visit. Clinical evaluations will include central corneal thickness, specular microscopy, as well as measurement of visual acuities at distance.

Sponsor: Aloha Vision Consultants

You may qualify if…

  • Adult patients undergoing age-related cataract surgery.
  • Planned use of the Catalys Precision Laser System.
  • Planned implantation of TECNIS intraocular lenses (IOLs).

You may not qualify if…

  • Moderate-severe any disease state (deemed by the surgeon) that could increase risk of complicated cataract surgery (ie, pseudoexfoliation syndrome, zonular dehiscence, history of eye trauma, and prior refractive surgery).

Where it's recruiting

Hawaii

‘Aiea

Source: ClinicalTrials.gov · NCT07176416 · last updated 2025-10-09

Effective Phaco Time and Endothelial Cell Loss When Using Veritas · TrialPath